Surrozen, Inc. (SRZN)
NASDAQ: SRZN · Real-Time Price · USD
22.76
+0.22 (0.98%)
Sep 4, 2026, 4:00 PM EDT - Market closed
Surrozen Market Cap
Surrozen has a market cap or net worth of $267.51 million as of September 4, 2026. Its market cap has increased by 148.91% in one year.
Market Cap
267.51M
Enterprise Value
171.79M
1-Year Change
148.91%
Ranking
Category
Stock Price
$22.76
ChartMarket Cap Chart
Since January 11, 2021, Surrozen's market cap has increased from $120.65M to $267.51M, an increase of 121.72%. That is a compound annual growth rate of 15.14%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 4, 2026 | 267.51M | 26.97% |
| Dec 31, 2025 | 210.69M | 351.80% |
| Dec 31, 2024 | 46.63M | 143.39% |
| Dec 29, 2023 | 19.16M | 10.72% |
| Dec 30, 2022 | 17.31M | -92.33% |
| Dec 31, 2021 | 225.58M | 86.96% |
| Jan 11, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| AC Immune | 282.37M |
| Lineage Cell Therapeutics | 280.73M |
| MacroGenics | 275.18M |
| Cartesian Therapeutics | 274.72M |
| Whitehawk Therapeutics | 268.51M |
| Anavex Life Sciences | 267.89M |
| YD Bio | 264.40M |
| Entrada Therapeutics | 263.22M |